Loading clinical trials...
Loading clinical trials...
Perampanel is a non-competitive antagonist of the AMPA ( 2-amino-3-(5-méthyl-3-hydroxy-1,2-oxazol-4-yl)) propanoïc acid receptors which was approved by the European Medicines Agency as adjunctive trea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT06425029 · Epilepsy, Refractory Epilepsy, and more
NCT05327387 · Medication Refractory Epilepsy Patients With Electrodes Already Implanted Based on Clinical Criteria for Standard Monitoring
NCT06304389 · Refractory Epilepsy
NCT05019885 · Drug Resistant Epilepsy, Medically Refractory Epilepsy, and more
NCT06524479 · Refractory Epilepsy, Sleep
Hôpital neurologique
Lyon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions